| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(03)00528-0 |
| P698 | PubMed publication ID | 14604575 |
| P50 | author | Ursula Wiedermann | Q23761381 |
| Heimo Breiteneder | Q47007147 | ||
| Josef Thalhamer | Q53059500 | ||
| Karin Hoffmann-Sommergruber | Q57059403 | ||
| P2093 | author name string | Dietrich Kraft | |
| Andreas Repa | |||
| Annick Mercenier | |||
| Catherine Daniel | |||
| Corinne Grangette | |||
| Romana Hochreiter | |||
| P2860 | cites work | Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen | Q74211594 |
| The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice | Q74284091 | ||
| Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997 | Q77057889 | ||
| Overview of gut flora and probiotics | Q77093898 | ||
| The intestinal microflora in allergic Estonian and Swedish 2-year-old children | Q77321890 | ||
| Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells | Q77373909 | ||
| Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes | Q77408022 | ||
| Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model | Q77999926 | ||
| Interaction of lactic acid bacteria with the gut immune system | Q78853845 | ||
| Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy | Q93926790 | ||
| Hay fever, hygiene, and household size | Q24674856 | ||
| Use of T7 RNA polymerase to direct expression of cloned genes | Q27860692 | ||
| Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial | Q28211907 | ||
| Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee | Q29615468 | ||
| Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells | Q33770489 | ||
| Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey | Q34094839 | ||
| Probiotics: effects on immunity | Q34130940 | ||
| Probiotics in man and animals | Q34505006 | ||
| Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus | Q36243797 | ||
| Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. | Q36326092 | ||
| Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals | Q36362607 | ||
| Skin test reactivity and number of siblings | Q36884202 | ||
| Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production | Q39516450 | ||
| Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora | Q39672297 | ||
| Basic and practical aspects of recombinant allergens | Q40421714 | ||
| Regulation of the development of type 2 T-helper cells in allergy | Q40502948 | ||
| Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults | Q40688912 | ||
| Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen. | Q40790811 | ||
| Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen | Q41022355 | ||
| Lactic acid bacteria as vaccine delivery vehicles | Q41174265 | ||
| A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections | Q43650387 | ||
| Intestinal microflora of Estonian and Swedish infants | Q47778356 | ||
| Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice | Q47784397 | ||
| The genetics and complexity of allergy and asthma | Q47834234 | ||
| Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. | Q51717643 | ||
| The inverse association between tuberculin responses and atopic disorder. | Q52891872 | ||
| Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. | Q54536971 | ||
| Parental farming protects children against atopy: longitudinal evidence involving skin prick tests | Q57030160 | ||
| Crossregulation Between Th1 and Th2 Cells | Q62748658 | ||
| Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses | Q69301356 | ||
| Half-life of murine IgE antibodies in the mouse | Q71707675 | ||
| WHO position paper on oral (sublingual) immunotherapy | Q73229859 | ||
| Efficient secretion of the model antigen M6-gp41E in Lactobacillus plantarum NCIMB 8826 | Q73633019 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pollen | Q79932 |
| pollen allergy | Q8194502 | ||
| lactic acid bacteria | Q13360072 | ||
| murine model | Q122890741 | ||
| P304 | page(s) | 87-95 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy | |
| P478 | volume | 22 |
| Q33676056 | A foreign protein incorporated on the Tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity |
| Q36699182 | Actual concept of "probiotics": is it more functional to science or business? |
| Q38824177 | Allergen immunotherapy for birch pollen-allergic patients: recent advances. |
| Q26750443 | Allergic diseases among children: nutritional prevention and intervention |
| Q35719834 | Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner |
| Q42161475 | Biocontainment strategies for live lactic acid bacteria vaccine vectors |
| Q36589520 | Construction of a recombinant allergen-producing probiotic bacterial strain: Introduction of a new line for a live oral vaccine against Chenopodium album pollen allergy |
| Q35832507 | Customized antigens for desensitizing allergic patients. |
| Q34988307 | Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor |
| Q38296706 | Developing therapies for peanut allergy |
| Q34261111 | Distinct immunomodulation of bone marrow-derived dendritic cell responses to Lactobacillus plantarum WCFS1 by two different polysaccharides isolated from Lactobacillus rhamnosus LOCK 0900 |
| Q91639905 | E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization |
| Q44308316 | Effect of inhaled inactivated Mycobacterium phlei in children with moderate asthma |
| Q35946659 | Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. |
| Q36680079 | Effects of lysed Enterococcus faecalis FK-23 on experimental allergic rhinitis in a murine model |
| Q44875794 | Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics. |
| Q33990842 | Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei |
| Q58863949 | Immunomodulatory function and in vivo properties of Pediococcus pentosaceus OZF, a promising probiotic strain |
| Q35741195 | Impact of lactic Acid bacteria on dendritic cells from allergic patients in an experimental model of intestinal epithelium |
| Q47346696 | Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy |
| Q35690028 | Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice |
| Q49201464 | L. plantarum WCFS1 enhances Treg frequencies by activating DCs even in absence of sampling of bacteria in the Peyer Patches. |
| Q82997042 | Lactic acid bacteria as adjuvants for sublingual allergy vaccines |
| Q34974711 | Live bacterial vaccines--a review and identification of potential hazards |
| Q55693712 | Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases. |
| Q33247595 | Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. |
| Q88605312 | Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis |
| Q37111626 | Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria |
| Q39474002 | Murine models for mucosal tolerance in allergy |
| Q42246982 | Neonatal colonization of germ-free mice with Bifidobacterium longum prevents allergic sensitization to major birch pollen allergen Bet v 1. |
| Q33705931 | Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization |
| Q40764032 | Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells |
| Q28727435 | Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy |
| Q33209363 | Potential and opportunities for use of recombinant lactic acid bacteria in human health |
| Q38828414 | Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates immunoglobulin levels and cytokines expression in whey proteins sensitised mice |
| Q43078767 | Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway |
| Q27027791 | Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology |
| Q36025631 | Production of Recombinant Peanut Allergen Ara h 2 using Lactococcus lactis. |
| Q27028100 | Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case |
| Q37961175 | Regulatory T cells in infection |
| Q28730670 | Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells |
| Q33577679 | Strategies of mucosal immunotherapy for allergic diseases |
| Q64240868 | Subcutaneous Immunization with Recombinant Expressing F1S1 Fusion Protein Induces Systemic and Mucosal Immune Responses in BALB/C Mice |
| Q33301738 | The European LABDEL project and its relevance to the prevention and treatment of allergies |
| Q36631447 | Therapeutic drug delivery by genetically modified Lactococcus lactis |
| Q46093319 | Toxoplasma gondii tachyzoite-extract acts as a potent immunomodulator against allergic sensitization and airway inflammation. |
| Q57717052 | Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy |
| Q33546633 | Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data |
Search more.